Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD
Primary Purpose
Gastroesophageal Reflux Disease
Status
Unknown status
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Full-Thickness-Gastroplication
Sponsored by
About this trial
This is an interventional trial for Gastroesophageal Reflux Disease
Eligibility Criteria
Inclusion Criteria:
- persistent or recurrent symptoms despite continuous medical treatment, at least one typical reflux symptom (heartburn/ regurgitation/dysphagia/epigastric pain) and/or at least one atypical reflux symptom (cough/ asthma/hoarseness/distortion of taste), pathologic esophageal acid exposure as documented by a reflux-related DeMeester score ≥14.7, and symptom correlation ≥50%, and/or reflux episodes >73.
Exclusion Criteria:
- any distinct hiatal hernia detectable by gastroscopy or barium radiography, dysphagia, esophageal strictures, poor physical status (American Society of Anesthesiologists (ASA) scores III and IV) and pregnancy.
Sites / Locations
- General public hospital Zell am SeeRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Full-Thickness-Gastroplication
Arm Description
Outcomes
Primary Outcome Measures
Quality of Life
Secondary Outcome Measures
Full Information
NCT ID
NCT01453985
First Posted
October 12, 2011
Last Updated
October 14, 2011
Sponsor
General Public Hospital Zell am See
1. Study Identification
Unique Protocol Identification Number
NCT01453985
Brief Title
Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD
Study Type
Interventional
2. Study Status
Record Verification Date
October 2011
Overall Recruitment Status
Unknown status
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
General Public Hospital Zell am See
4. Oversight
5. Study Description
Brief Summary
This is a prospective study to extensively evaluate subjective patient parameters on quality of life, reflux-symptoms, side effects, medication-use and measurements of esophageal manometry and Impedance-pH-Monitoring after Full-Thickness-Gastroplication.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastroesophageal Reflux Disease
7. Study Design
Study Phase
Not Applicable
8. Arms, Groups, and Interventions
Arm Title
Full-Thickness-Gastroplication
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Full-Thickness-Gastroplication
Primary Outcome Measure Information:
Title
Quality of Life
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Eligibility Criteria
Inclusion Criteria:
persistent or recurrent symptoms despite continuous medical treatment, at least one typical reflux symptom (heartburn/ regurgitation/dysphagia/epigastric pain) and/or at least one atypical reflux symptom (cough/ asthma/hoarseness/distortion of taste), pathologic esophageal acid exposure as documented by a reflux-related DeMeester score ≥14.7, and symptom correlation ≥50%, and/or reflux episodes >73.
Exclusion Criteria:
any distinct hiatal hernia detectable by gastroscopy or barium radiography, dysphagia, esophageal strictures, poor physical status (American Society of Anesthesiologists (ASA) scores III and IV) and pregnancy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rudolph Pointner, Prof.
Phone
004365427772210
Email
ac.sekretariat@kh-zellamsee.at
Facility Information:
Facility Name
General public hospital Zell am See
City
Zell am See
ZIP/Postal Code
5700
Country
Austria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Oliver O Koch, MD
Email
o.koch@sbg.at
First Name & Middle Initial & Last Name & Degree
Oliver O Koch, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
23021166
Citation
Koch OO, Kaindlstorfer A, Antoniou SA, Spaun G, Pointner R, Swanstrom LL. Subjective and objective data on esophageal manometry and impedance pH monitoring 1 year after endoscopic full-thickness plication for the treatment of GERD by using multiple plication implants. Gastrointest Endosc. 2013 Jan;77(1):7-14. doi: 10.1016/j.gie.2012.07.033. Epub 2012 Sep 26.
Results Reference
derived
Learn more about this trial
Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD
We'll reach out to this number within 24 hrs